FLURESS (Akorn, Inc.)


Welcome to the PulseAid listing for the FLURESS drug offered from Akorn, Inc.. This Diagnostic Dye [EPC],Dyes [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Fluorescein Sodium and Benoxinate Hydrochloride
SUBSTANCE NAME: FLUORESCEIN SODIUM; BENOXINATE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Diagnostic Dye [EPC],Dyes [MoA]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1995-02-01
END MARKETING DATE: 0000-00-00


FLURESS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFLURESS from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5; 4(mg/mL; mg/mL)
START MARKETING DATE: 1995-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-640_b63db481-5b90-4817-b2f9-940ba2473d0b
PRODUCT NDC: 17478-640
APPLICATION NUMBER:

Other FLUORESCEIN SODIUM; BENOXINATE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.FLURESS
OCuSOFT, Inc.Flurox